Piceatannol Protects Human Retinal Pigment Epithelial Cells against Hydrogen Peroxide Induced Oxidative Stress and Apoptosis through Modulating PI3K/Akt Signaling Pathway.
Yiming HaoJie LiuZiyuan WangLiangli Lucy YuJing WangPublished in: Nutrients (2019)
This study investigated the protective effect and the molecular mechanism of piceatannol on hydrogen peroxide (H2O2)-induced retinal pigment epithelium cell (ARPE-19) damage. Piceatannol treatment significantly inhibited H2O2-induced RPE cell death and reactive oxygen species (ROS) generation by 64.4% and 75.0%, respectively. Results of flow cytometry showed that H2O2-induced ARPE-19 cells apoptosis was ameliorated by piceatannol supplementation, along with decreased relative protein expressions of Bax/Bcl-2, Cleave-Caspase-3, and Cleave-PARP. Moreover, piceatannol treatment induced NF-E2-related factor 2 (Nrf2) signaling activation, which was evidenced by increased transcription of anti-oxidant genes, glutamate-cysteine ligase catalytic subunit (GCLc), SOD, and HO-1. Knockdown of Nrf2 through targeted siRNA alleviated piceatannol-mediated HO-1 transcription, and significantly abolished piceatannol-mediated cytoprotection. LY294002 (PI3K inhibitor) dramatically blocked piceatannol-mediated increasing of Nrf2 nuclear translocation, HO-1 expression, and cytoprotective activity, indicating the involvement of PI3K/Akt pathway in the cytoprotective effect of piceatannol. The results from this suggest the potential of piceatannol in reducing the risk of age-related macular degeneration.
Keyphrases
- pi k akt
- cell cycle arrest
- hydrogen peroxide
- signaling pathway
- cell death
- oxidative stress
- induced apoptosis
- diabetic rats
- high glucose
- nitric oxide
- reactive oxygen species
- endothelial cells
- cell proliferation
- dna damage
- flow cytometry
- poor prognosis
- drug induced
- epithelial mesenchymal transition
- dna methylation
- age related macular degeneration
- genome wide
- mass spectrometry
- gene expression
- risk assessment
- high resolution
- stem cells
- cell therapy
- binding protein
- bone marrow
- amyotrophic lateral sclerosis
- atomic force microscopy
- bioinformatics analysis